Back to Archived Journals » Advanced Health Care Technologies » Volume 4

Smartphone electrocardiogram monitoring: current perspectives

Authors Walker AL, Muhlestein JB

Received 19 October 2017

Accepted for publication 26 March 2018

Published 8 June 2018 Volume 2018:4 Pages 15—24


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Gozde Durmus

Andrew L Walker,1 Joseph B Muhlestein2

1University of Utah School of Medicine, Department of Internal Medicine, Salt Lake City, UT, USA; 2Intermountain Medical Center Heart Institute, Salt Lake City, UT, USA

Abstract: Three-fourths of Americans now own smartphones. Mobile health applications are becoming increasingly common for the management of various chronic diseases, and have the potential to improve health outcomes. One of these is the sector of smartphone electrocardiogram (ECG) technology. Previously, obtaining an ECG has involved a bulky machine requiring medical training to operate. Most of the smartphone ECG technologies involve a single-lead ECG obtained on a small device that communicates with a smartphone. Many companies offer smartphone ECG technology. The most prevalent and studied of these is the Kardia Mobile device by AliveCor®, which has a Food and Drug Administration-approved algorithm for detecting atrial fibrillation (AF). Here, we specifically review smartphone ECG technology including model specifications, cost, and ongoing clinical trials. We also review clinical uses of the technology including screening and monitoring of AF, QT monitoring during initiation of rhythm control medications, and the ability to accurately detect ST-elevation myocardial infarction.

smartphone, ECG, AliveCor, Kardia Mobile, Cardiac Designs, ECG Check, D-Heart, QardiaCore, EPI Mini, iHealth Rhythm, atrial fibrillation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]